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INCREASED SUSCEPTIBILITY TO SHIGELLA ENDOTOXIN AND TO HISTAMINE
AFTER IMMUNIZATION TO H. PERTUSSIS
Acquired sensitivity subsequent to vaccination is a significant problem in
prophylactic medicine, and the observations which are to be described seem
pertinent to this problem. These studies concern immunization with Hemo-
philus pertussis vaccine which renders mice extremely susceptible to subse-
quent injections of the same vaccine as well as other bacterial preparations
and histamine. It is, therefore, possible to compare the susceptibility of
normal mice of different ages to H. pertussis vaccine and after vaccination
to challenge inoculations of the various preparations. Histamine has been
included because of its repeated link with sensitivity reactions even though
its role has not been rigidly established.
In utilizing the technique of altered susceptibility through pertussis
vaccination it has been found that older mice are much less able to with-
stand an initial injection of the vaccine than are younger animals. Once vac-
cinated, all mice pre-treated with pertussis have a markedly decreased
resistance to a subsequent inoculation of Shigella endotoxin. In an attempt
to isolate the responsible fraction, mice have been tested with purified
preparations of polysaccharide from Shigella dysenteriae.
MATERIALS AND METHODS
A complete procedure for sensitization with H. pertussis has been presented else-
where'l and only the total dosage and routine of injections will be included in the
description of the particular experiments.
The mice used in these studies were strain CFW and formed two major groups: old
ex-breeders more than one year of age, weighing 30-32 gm., and young mice less than
one month old, weighing 18-19 gm. Most experiments were with female mice and when
males were used, a special note is made. In our experiments we used the "O" antigen
polysaccharide of Shigella dysenteriae, kindly supplied to us by Dr. H. P. Treffers
of this Department. It was prepared by the extraction of Shigella dysenteriae accord-
ing to the phenol method of W. T. J. Morgan. Two preparations were required and
are designated in the tables below as lots X82 and $83.
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OBSERVATIONS
Vaccination uith pertussis and the effect of age. In these studies the age
and sex of the mice were always considered. In the first experiment old
mice, ex-breeders more than one year of age, and young mice less than one
month old were all injected intraperitoneally with 15 billion cells of H.
pertussis vaccine in a single dose. Only 57 of 96, or 59%o, of the older mice
survived in comparison with 112 of 117, or 97%o, of the younger group,
death occurring from 4 to 12 hours after the injection. The difference
between young and old is statistically significant with p = 0.01. When
young mice were injected with 30 billion cells of the pertussis vaccine in
two intraperitoneal doses of 15 billion cells each, given one day apart, 46
TABLE 1. SENSITIVITY TO HISTAMINE PRODUCED BY H. PERTUSSIS VACCINE
IN DIFFERENT AGES OF MICE
Old ex-breeders Young mice
Dose of histamine mg. 15 billion cells 15 billion cells 30 billion cells
per kilo body weight H. pertussis H. pertussis H. pertussis
25 mg. 9/26 5/6
50 mg. 3/23 10/10 2/6
75 mg. 3/3
100 mg. 6/7 0/5
200 mg. 3/4
of 54 animals, or 85%o, survived. Thus, it is shown that H. pertussis vaccine
is much more toxic for older mice than for young animals of the same strain.
Susceptibility to histamine after pertussis vaccination. Survivors from the
preceding experiment, having been inoculated with H. pertussis, were given
an intraperitoneal injection of histamine five days later. The data are in-
cluded in Table 1. According to previous published experiments9 histamine
is not toxic for young normal mice in doses of 2,000 mg./kg., but is toxic for
pertussis-treated animals in doses less than 50 mg./kg. Old ex-breeders
which had survived the injection of 15 billion cells of H. pertussis vaccine
given in a single dose were much more susceptible than treated mice of a
younger age. Death occurred 4-12 hours after the injection of histamine. In
the older group, 9 of 26, 35%o, survived a dosage of 25 mg. of histamine/kg.
and only 3 of 23, 13%o, withstood 50 mg. of histamine/kg. By comparison,
young mice which were relatively unaffected by the injection of 15 billion
cells of H. pertussis vaccine were better able to withstand the challenge of
histamine, 3 of 4, or 75%o, surviving a dosage of 200 mg./kg. and 23 of 26,
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or 90%7o, surviving smaller doses. The difference in susceptibility to his-
tamine between young and old mice treated with pertussis is quite signifi-
cant statistically with p = 0.01. However, when young mice were inocu-
lated with 30 billion pertussis organisms injected in two equal doses on two
consecutive days, none of 5 survived a dosage of 200 mg. of histamine/kg.
The difference in susceptibility to histamine between young mice pre-treated
with 30 billion cells and those pre-treated with 15 billion cells is also of
statistical significance (p - 0.01).
Susceptibility to Shigella endotoxin. Older animals can be pre-treated
with H. pertussis with a mortality of approximately 10%o by a procedure
TABLE 2. SUSCEPTIBILITY OF NORMAL AND SENSITIZED MICE TO
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of injecting 15 billion cells in 3 doses of 5 billion cells each on 3 consecutive
days. Ex-breeders, 44 in number, were thus treated and then injected intra-
peritoneally with various dosages of Shigella endotoxin. The results are
shown in column a of Table 2. In test doses from 0.0075 mg. to 1.0 mg., not
one animal survived; 3 of 6, 50%, survived after the inoculation of 0.005
mg.; all of 4 survived doses of 0.001 mg. to 0.002 mg. When death occurred,
it came 4-12 hours after the injection of the endotoxin.
To provide a comparison, 37 normal ex-breeders were also injected with
varying dosage of Shigella endotoxin (column b of Table 2). All of 5 ani-
mals succumbed to a dose of 1 mg.; 1 of 6, 17%, survived an injection of
0.5 mg.; 4 of 5, 80%o, withstood 0.06 mg. Thus, the effective challenging
dose is approximately 100 times as great for normal animals as for
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the normal and vaccinated female ex-breeders is statistically significant
(p = 0.01) for the dosage ranging from 0.0075 to 0.500 mg.
The preceding experiment has been repeated using a second preparation
(#83) of endotoxin polysaccharide, the results being summarized in Table
3. The largest dose which any pertussis-treated ex-breeder survived was
0.015 mg. or 1/27 or 0.4 mg., the largest dose withstood by a normal ex-
breeder. In the dosage range of 0.015 to 0.400 mg. this difference was
significant (p = 0.04).
In comparing the susceptibility to Shigella endotoxin as related to sex,
96 normal ex-breeders, 59 male and 37 female, were challenged with vary-
TABLE 3. SUSCEPTIBILITY OF NORMAL AND SENSITIZED MICE TO
SHIGELLA ENDOTOXIN, LOT 83
Ex-breeders sens. Young mice Young mice
wvith 15 billion sens. with sens. with Normal
Dose H. pertussis cells Ex-breeder 15 billion 30 billion young
dysenteriae (a) normal cells cells mice
endotoxin * (b) (c) (d) (e)
0.0006 mg. .... .... ... ... ....
2.0 mg. 0/4 0/7 0/3 3/13
0.4 mg. 0/4 1/11 0/8 0/2 6/10
0.08 mg. 0/8 4/7 6/9 0/5 4/4
0.015 mg. 2/12 3/4 3/4 1/5 4/4
0.003 mg. 2/7 2/3
0.0006 mg. 7/7 5/6
* Fractions indicate number of survivors out of number exposed.
ing dosage of endotoxin (Table 2, columns c and d). The older male mice
appear to be slightly less susceptible to the toxin than the normal female
ex-breeders (p = 0.04 for the dosage range from 0.25 to 0.50 mg.).
In a consideration of age, it was shown (Table 3, columns b and e) that
normal young mice are more resistant to the Shigella polysaccharide than
normal old ex-breeders, since the latter succumbed more readily to the test
doses (p = 0.01). However, by using a large inoculum of pertussis vaccine
to pre-treat these young mice, their ability to withstand the inoculation of
endotoxin could be markedly reduced (p = 0.02 for 0.015 to 0.080 mg.).
DISCUSSION
The increased susceptibility to Shigella polysaccharide which is shown by
mice immunized with H. pertussis vaccine extends our earlier observations
concerning the capacity of this vaccine to induce a non-specific sensitivity
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to vaccines of several species of Gram negative bacteria, as well as sensitiv-
ity to the homologous antigen.'l The latter observation has been substanti-
ated recently by Kind.8 These studies would indicate certain significant
ramifications concerning the role of non-specific sensitization in the resist-
ance and susceptibility to infection. For example, when mice are immunized
with H. pertussis vaccine they become resistant to infection by the homo-
logous organism but, when compared to normal, non-treated animals, they
are found to be more susceptible to infection with other Gram negative
bacteria such as Proteus vulgaris OX19, Pasteurella multocida, and
Brucella suis'1'
One possible explanation of this phenomenon is that the Gram negative
bacteria contain a common antigenic substance which has sensitized the
animals. That there is an antigen in common is supported by the papers of
Clark, et al.2 and White,18 who have shown a common protein among the
Salmonella, Flexner, Coli, and Proteus organisms. The current experiments
are of special interest, however, since a highly purified polysaccharide of
S. dysenteriae has served as the challenging agent. Furthermore, the use of
this purified compound has permitted the more precise measurement of the
degree of susceptibility of the treated animals according to age and sex as
well as the difference in susceptibility between these animals and normal
controls. In some instances the differences was as much as a hundred-fold.
The significance of the increased susceptibility to histamine is more
difficult to comprehend. Although the older pre-treated mice are much more
susceptible than the younger vaccinated animals, the relative resistance of
the young is significantly reduced by more intense pre-treatment with per-
tussis. While it is known that histamine, when given to normal animals in
adequate dosage intravenously, will mimic the species peculiarities of ana-
phylactic shock and mode of death, its role in sensitivity reactions is cer-
tainly not established. It would, therefore, be most presumptuous to postu-
late why pre-treatment with pertussis will lower the physiological threshold
to histamine.
The data obtained from these studies may be correlated into several note-
worthy facts. Perhaps most important is the observation that older mice are
much more susceptible to an initial injection of pertussis vaccine than are
the younger animals. This is supported by the work of Kind' cited above
and by Burky,1 who showed that young rabbits were not susceptible to a
dosage of staphylococcal toxin lethal for adults of the same species. It may
well be that this phenomenon is associated with sensitization during life,
possibly through the long exposure of adult animals to Gram negative
organisms living in the intestinal tract.'
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A second significant fact is that vaccination to H. pertussis will render
mice extremely susceptible to a subsequent inoculation of a purified poly-
saccharide of S. dysenteriae. Similarly, pertussis vaccination will increase
susceptibility to dosages of histamine otherwise innocuous. Although young
mice, pre-treated with H. pertussis vaccine were less susceptible to Shigella
polysaccharide and less affected by the challenging inoculation of histamine,
the injection of larger preparatory doses of vaccine markedly diminished
the relative resistance of the young.
The r6le of H. pertussis in "sensitizing" these animals is certainly not
clear and there are related phenomena with pertussis which ought to be
mentioned. Malkiel and Kirchheimer' induced tuberculin sensitivity in mice
by the inoculation of a mixture of BCG and H. pertussis vaccine. Similarly,
Malkiel and Hargis4 produced anaphylactic shock in mice by the inocula-
tion of horse serum subsequent to preparatory injections of H. pertussis
vaccine and horse serum.
In related studies Pittman"7 discussed the difference between male and
female mice in sensitization to H. pertussis vaccine and also reported on the
sensitization of mice by intranasal administration of H. pertussis culture.
SUMMARY
1. Older mice are much less able to withstand injections of H. pertussis
vaccine than young mice of the same sex and strain.
2. The injection of H. pertussis vaccine increases the susceptibility of
mice to injections of Shigella endotoxin and of histamine.
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